“The current situation has uncovered some structural weaknesses within the EU’s medicines offer chain and a superior dependence on non-EU nations for active pharmaceutical ingredients,” Kyriakides said. She encouraged that supply chain troubles be addressed in an EU pharmaceutical approach envisioned being introduced by the tip in the 12 mont